GEM

Invitation to Bid – INJ AMPHOTERICIN B 50MG,INJ CASPOFUNGIN ACETATE 50MG INJ,INJ CASPOFUNGIN ACETATE 70 MG INJ,INJ CEFT in GORAKHPUR, UTTAR PRADESH

Posted

29 May 2025, 10:50 am

Deadline

19 Jun 2025, 11:00 am

EMD

₹32,000

Value

₹70,09,646

Progress

RA
Issue29 May 2025, 10:50 am
Reverse Auction22 Aug 2025, 03:00 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

18673

Bid Type

Two Packet Bid

Categories 3

All India Institute Of Medical Sciences (aiims) has released a public tender for INJ AMPHOTERICIN B 50MG, INJ CASPOFUNGIN ACETATE 50MG INJ, INJ CASPOFUNGIN ACETATE 70 MG INJ, INJ CEFTAZIDIME 1GM INJ, INJ DICLOFENAC SODIUM 75MG Or 3ML, INJ ETOPHYLLINE 84. 7MG plus THEOPHYLLINE 25. 3MG, INJ IMIPENEM 1GM AND CILASTATIN IP 1 GM, INJ LEVOSULPRIDE 25MG, INJ METHYLPREDNISOLONE 1 GM, INJ METRONIDAZOLE 500MG or 100ML -100ML, INJ PHYTOMENADIONE 10MG or ML - 1ML, INJ RABIES VACCINE INJ 2. 5IU, INJ TERLIPRESSIN 1MG, INJ VALETHAMATE 8MG or ML, SODIUM PHOSPHATE ENEMA 100ML, INFUSION L- ORNITHINE L-ASPARTATE 500MG, SYRUP CETRIZINE 5MG or 5ML, HUMAN NORMAL IMMUNOGLOBULIN as per Specs, INJ AZTREONAM USP 1000MG, INJ COLISTIMETHATE SODIUM 3000000 3M IU, INJ POLYMYXIN B SULPHATE 500000 IU INJ, INJ TEICOPLANIN 400 MG, INJ TIGECYCLINE 50MG INJ, INJ CEFTAZIDIME 2GM INJ plus AVIBACTAM 0. 5GM in GORAKHPUR, UTTAR PRADESH. Quantity: 18673. Submission Deadline: 19-06-2025 11: 00: 00. Download documents and apply online.

Bill of Quantities (BOQ) 24 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 INJ AMPHOTERICIN B 50MG Description1 437 vial [email protected] 30
2 INJ CASPOFUNGIN ACETATE 50MG INJ Description2 36 vial [email protected] 30
3 INJ CASPOFUNGIN ACETATE 70 MG INJ Description3 15 vial [email protected] 30
4 INJ CEFTAZIDIME 1GM INJ Description4 225 vial [email protected] 30
5 INJ DICLOFENAC SODIUM 75MG Or 3ML Description5 3,849 ampoule [email protected] 30
6 INJ ETOPHYLLINE 84.7MG plus THEOPHYLLINE 25.3MG Description6 31 ampoule [email protected] 30
7 INJ IMIPENEM 1GM AND CILASTATIN IP 1 GM Description7 514 vial [email protected] 30
8 INJ LEVOSULPRIDE 25MG Description8 624 ampoule [email protected] 30
9 INJ METHYLPREDNISOLONE 1 GM Description9 99 vial [email protected] 30
10 INJ METRONIDAZOLE 500MG or 100ML -100ML Description10 7,367 bottle [email protected] 30
11 INJ PHYTOMENADIONE 10MG or ML - 1ML Description11 349 ampoule [email protected] 30
12 INJ RABIES VACCINE INJ 2.5IU Description12 600 ampoule [email protected] 30
13 INJ TERLIPRESSIN 1MG Description13 90 ampoule [email protected] 30
14 INJ VALETHAMATE 8MG or ML Description14 225 ampoule [email protected] 30
15 SODIUM PHOSPHATE ENEMA 100ML Description15 547 bottle [email protected] 30
16 INFUSION L-ORNITHINE L-ASPARTATE 500MG Description16 350 ampoule [email protected] 30
17 SYRUP CETRIZINE 5MG or 5ML Description17 30 bottle [email protected] 30
18 HUMAN NORMAL IMMUNOGLOBULIN as per Specs Description18 15 vial [email protected] 30
19 INJ AZTREONAM USP 1000MG Description19 800 vial [email protected] 30
20 INJ COLISTIMETHATE SODIUM 3000000 3M IU Description20 400 vial [email protected] 30
21 INJ POLYMYXIN B SULPHATE 500000 IU INJ Description21 570 vial [email protected] 30
22 INJ TEICOPLANIN 400 MG Description22 700 vial [email protected] 30
23 INJ TIGECYCLINE 50MG INJ Description23 400 vial [email protected] 30
24 INJ CEFTAZIDIME 2GM INJ plus AVIBACTAM 0.5GM Description24 400 vial [email protected] 30

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

8

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Reverse Auction Schedule

Completed

Start

22 Aug 2025, 03:00 pm

End

01 Oct 2025, 10:00 am

Duration: 955 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

What are the eligibility requirements for participating in tenders for PICU and RICU drugs?

The eligibility requirements include being a registered entity, possessing the requisite licenses for pharmaceutical distribution, and having prior experience in supplying medications to health departments. Bidders must also be compliant with relevant health regulations.

What certificates are required to submit with the tender?

Bidders must provide quality assurance certificates, product registration certificates, and compliance documents with Good Manufacturing Practices (GMP). These ensure that the medicines meet necessary health standards.

How can bidders register to participate in the tender?

Bidders need to register on the GEM portal and create a profile that includes all relevant business information. Once registered, they can access the tender document and submit proposals according to the guidelines laid down in the tender description.

What document formats are accepted for the tender submission?

Bidders should submit their proposals in PDF or Word format as specified in the tender documentation. It's crucial to follow the file naming conventions provided to avoid any issues during the evaluation process.

What technical specifications must be aligned with the tender requirements?

The technical specifications must include detailed descriptions of the product, its composition, efficacy data, and quality certifications. These documents help in assessing the suitability of the tender submission in meeting health and safety standards.

What are the payment terms and security requirements for this tender?

Successful bidders will be required to provide a Performance Security, which is a percentage of the bid value, to ensure contract compliance. Payments shall be made upon delivery and inspection of the goods against the contract requirements, following the acceptance of the products as per stipulated quality standards.

How will the evaluation and selection process be conducted?

The selection will be based on a thorough evaluation of the technical and financial proposals. Bids that meet the predetermined criteria for quality and pricing will be prioritized for contract awarding, ensuring an objective and transparent procurement process.

What benefits do MSEs and startups receive from this tender?

MSEs and startups can take advantage of relaxed eligibility criteria and additional support initiatives aimed at fostering local business participation. This is in line with promoting Make in India policies and enhancing local procurement initiatives.

What are the key timelines for submission and evaluation?

While specific dates are variable, bidders are advised to closely monitor the GEM portal for announcements regarding submission deadlines, evaluation timelines, and notifications of results post-evaluation. This ensures that all participants stay informed throughout the tender process.